LENZ vs AAPL: Which Stock is Better?

Side-by-side comparison of Lenz Therapeutics Inc and Apple Inc in 2026

Comparison Updated:

LENZ

Lenz Therapeutics Inc

$10.18

AAPL

Apple Inc

$269.84

Key Metrics Comparison

MetricLENZAAPLWinner
Market Cap$319.19MN/ALENZ
P/E RatioN/A33.32AAPL
EPS (TTM)$N/A$8.11AAPL
Revenue Growth0.0%0.2%AAPL
Gross Margin97.8%47.3%LENZ

Analyze LENZ

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LENZ or AAPL a better investment?

Comparing LENZ and AAPL: Lenz Therapeutics Inc has a market cap of $319.19M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LENZ and AAPL?

LENZ (Lenz Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LENZ or AAPL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LENZ or AAPL?

AAPL has higher revenue growth at 0.2% vs 0.0% for LENZ.

Which company is more profitable: LENZ or AAPL?

Lenz Therapeutics Inc (LENZ) has higher gross margins at 97.8% compared to 47.3% for AAPL.

Which is the larger company: LENZ or AAPL?

Lenz Therapeutics Inc (LENZ) is larger with a market cap of $319.19M compared to N/A for AAPL.

Should I buy LENZ or AAPL in 2026?

Both LENZ and AAPL have investment merit. LENZ trades at $10.18 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LENZ and AAPL stock?

Key differences: Market Cap ($319.19M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (97.8% vs 47.3%).

Popular Stock Comparisons